Adverse drug reactions causing admission to a paediatric hospital

PLoS One. 2012;7(12):e50127. doi: 10.1371/journal.pone.0050127. Epub 2012 Dec 4.

Abstract

Objective(s): To obtain reliable information about the incidence of adverse drug reactions, and identify potential areas where intervention may reduce the burden of ill-health.

Design: Prospective observational study.

Setting: A large tertiary children's hospital providing general and specialty care in the UK.

Participants: All acute paediatric admissions over a one year period.

Main exposure: Any medication taken in the two weeks prior to admission.

Outcome measures: Occurrence of adverse drug reaction.

Results: 240/8345 admissions in 178/6821 patients admitted acutely to a paediatric hospital were thought to be related to an adverse drug reaction, giving an estimated incidence of 2.9% (95% CI 2.5, 3.3), with the reaction directly causing, or contributing to the cause, of admission in 97.1% of cases. No deaths were attributable to an adverse drug reaction. 22.1% (95% CI 17%, 28%) of the reactions were either definitely or possibly avoidable. Prescriptions originating in the community accounted for 44/249 (17.7%) of adverse drug reactions, the remainder originating from hospital. 120/249 (48.2%) reactions resulted from treatment for malignancies. The drugs most commonly implicated in causing admissions were cytotoxic agents, corticosteroids, non-steroidal anti-inflammatory drugs, vaccines and immunosuppressants. The most common reactions were neutropenia, immunosuppression and thrombocytopenia.

Conclusions: Adverse drug reactions in children are an important public health problem. Most of those serious enough to require hospital admission are due to hospital-based prescribing, of which just over a fifth may be avoidable. Strategies to reduce the burden of ill-health from adverse drug reactions causing admission are needed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • Drug-Related Side Effects and Adverse Reactions*
  • Hospitals, Pediatric*
  • Humans
  • Patient Admission*
  • Prospective Studies
  • Vereinigtes Königreich